SCHEMBL18794865

SCHEMBL18794865

O=C1NCCCCC1(F)c1ccc(Cl)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 12/20 0.46
SLC6A4 P31645 11/20 0.43
SLC6A2 P23975 6/20 0.43
GRIN1 Q05586 2/20 0.34
GRIN2A Q12879 2/20 0.34
ABCC9 O60706 1/20 0.34
ABCC8 Q09428 1/20 0.34
KCNJ11 Q14654 1/20 0.34
KCNJ8 Q15842 1/20 0.34
CCR1 P32246 1/20 0.33
CYP2D6 P10635 1/20 0.33
APP P05067 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
AKR1C3 P42330 1/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
AKR1C2 P52895 1/20 0.33
APH1B Q8WW43 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18794816 0.89 SLC6A4 (0.42) SLC6A3SLC6A4SLC6A2CYP2D6CYP3A4
SCHEMBL18794831 0.81 DRD2 (0.38) SLC6A3SLC6A4SLC6A2GRIN1GRIN2A
SCHEMBL18822478 0.81 DRD2 (0.38) SLC6A3SLC6A4SLC6A2GRIN1GRIN2A
SCHEMBL18822477 0.81 DRD2 (0.38) SLC6A3SLC6A4SLC6A2GRIN1GRIN2A
SCHEMBL18794837 0.79 SLC6A9 (0.38) SLC6A3SLC6A4SLC6A2GRIN1GRIN2A
SCHEMBL18794830 0.78 GRIN1 (0.33) SLC6A3SLC6A4SLC6A2GRIN1GRIN2A
SCHEMBL18794833 0.76 METAP2 (0.38) GRIN1GRIN2A
SCHEMBL18794813 0.76 METAP2 (0.41) GRIN1GRIN2APSEN1PSEN2APH1B
SCHEMBL18794821 0.75 P2RX7 (0.33) GRIN1GRIN2APSEN1PSEN2APH1B
SCHEMBL18794819 0.74 GRIN1 (0.51) GRIN1GRIN2ACYP2C9CXCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017070793-A1 NOVEL FLUORINATED HETEROCYCLE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS TRILLIUM THERAPEUTICS INC. (CA) 2017-05-04 WO claimed
WO-2017070793-A1 NOVEL FLUORINATED HETEROCYCLE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS TRILLIUM THERAPEUTICS INC. (CA) 2017-05-04 WO disclosed
WO-2017070793-A1 NOVEL FLUORINATED HETEROCYCLE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS TRILLIUM THERAPEUTICS INC. (CA) 2017-05-04 WO disclosed